Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Apr 1, 2016

5262_dirs_2016-04-01_24b9f973-f087-462d-b287-e2744abe67a5.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9532T

GlaxoSmithKline PLC

01 April 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4 R(1)(c) GlaxoSmithKline plc (GSK) was advised on 1 April 2016 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 31 March 2016, at a price of $40.55 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401(K) plan:

Connected Person Number of ADSs
Dr K Slaoui (Connected Person of Dr M M Slaoui) 9

V A Whyte

Company Secretary

1 April 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZFLFBQZFFBBD